In certain cancer cases, pinpointing the exact origin of the cancer is challenging, which complicates treatment decisions. Specific cancer treatments are tailored to different cancer types, and not knowing where the cancer originated from hinders treatment options.

Fortunately, a collaboration between researchers at MIT and the Dana-Farber Cancer Institute has unveiled a machine-learning model, named OncoNPC, that can predict a tumor's origin by analyzing the genetic sequence of about 400 genes.

Upon testing, the model showcased an impressive ability to correctly identify the origins of tumors 80% of the time. For tumors where predictions were made with high confidence, the accuracy surged to about 95%. This is monumental for cases classified as cancers of unknown primary (CUP), representing 3 to 5 percent of all cancer patients.

Utilizing the OncoNPC model on about 900 CUP tumors revealed that it could make high-confidence predictions for 40% of them. Further validating the model's precision, the predicted cancer types corresponded with patients' survival times, aligning with known prognoses for those cancer types.

Additionally, the model's implementation could have reshaped treatment decisions for patients. A subset of CUP patients who received treatment congruent with the model's predictions had more favorable outcomes compared to those who received mismatched treatments. The researchers emphasized that a significant portion of patients could benefit from existing precision treatments if the cancer's origin was identified through their model.

The team, funded by multiple institutions, including the National Institutes of Health, is optimistic about enhancing the model's capabilities. Incorporating other data types like radiology and pathology images aims to equip the model to offer comprehensive insights, potentially guiding optimal treatment options.

To view the original source, visit: MIT News

Written by the digital marketing team at Creative Programs & Systems: https://www.cpsmi.com/

• Compact, Cost-Effective Laser-Powered Particle Accelerators: A Game Changer for the Industry
• Prenuvo Launches FDA-Cleared AI-Powered Whole Body MRI Screening Products
• Linear Particle Accelerators Market: A Thriving Industry with Expanding Horizons
• Prevention and Screening: Major Contributors to Saving Lives in Five Key Cancer Types
• Can AI Improve Early Detection of Breast Cancer in MRI Studies?
• BAT: A Revolutionary Garment Enhancing Radiation Safety for Healthcare Professionals
• Research Advocates for Advanced Precision Radiation Therapy in Lung Cancer
• Advancements in Lung Cancer Detection and Treatment Monitoring
• Diagnosing Multiple Sclerosis (MS)
• Researchers Have Created a Perovskite X-ray Detector for Medical Imaging Applications